94 results
Page 2 of 5
8-K
EX-1.1
2ml4a8nri9100e69r6
12 Oct 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:46pm
424B5
jj6frt5gutiuh6rm06
8 Oct 21
Prospectus supplement for primary offering
5:13pm
424B5
ko4 aj8icr6j
6 Oct 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
5od0zb2hzthbb5
6 Oct 21
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-1.1
j7l9p87q
8 Sep 21
Other Events
7:10am
424B5
j4oeklanatc5scqhe
8 Sep 21
Prospectus supplement for primary offering
7:01am
8-K
EX-99.3
iq288ld8 po
8 Sep 21
Other Events
6:22am
8-K
EX-99.2
m66q1ypb rxkx7r3p8uj
8 Sep 21
Other Events
6:22am
8-K
EX-2.1
b3tr0xc7hk
30 Jun 21
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
6:04am
8-K
EX-99.1
8fxh e8swt9zes1w9df
30 Mar 21
Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
12:00am
8-K
EX-99.1
5fxes5qob
10 Nov 20
Osmotica Pharmaceuticals plc Reports Third Quarter 2020 Results and Provides Business Updates
4:23pm
8-K
EX-99.2
et4neyo34gk3 3njuse0
11 Aug 20
Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates
4:40pm